Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew plcの流動比率は2.02、純利益率は10.13、1株当たり売上高は$7.06です。
Smith & Nephew plcの収益はセグメントまたは地域別にどのように分けられていますか?
Smith & Nephew plc の最大収益セグメントは Mass Notification Using Text Messages and Automated Telephone Calls で、最新の利益発表における収益は 3,653,380 です。地域別に見ると、United States が Smith & Nephew plc の主要市場であり、収益は 4,191,084 です。